TAMI MCCOY: Open Payments
NPI 1952716136 · HOLLY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 81 payments from 26 companies in 2025. Trend: 2023 $1,287 · 2024 $1,373 · 2025 $1,831
Food & beverage: $1,811Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $234 |
| Amgen Inc. | 8 | $161 |
| Corcept Therapeutics | 5 | $151 |
| Mannkind Corporation | 7 | $141 |
| Tandem Diabetes Care, Inc. | 6 | $111 |
| Sequel Med Tech, LLC | 5 | $103 |
| Radius Health, Inc. | 3 | $100 |
| CeQur Corporation | 1 | $95 |
| Insulet Corporation | 4 | $87 |
| Abbott Laboratories | 4 | $80 |
Products named: Ozempic, TEPEZZA, Korlym, AFREZZA, t:slim X2 Insulin Pump with Control-IQ, TWIIST, Tymlos, CeQur Simplicity.
Industry payments across GA — which companies pay providers there.
